""

Eurofins Scientific, a leading global provider of analytical testing and laboratory services, has reported weak organic growth, which is attributed to cyclical factors. According to the company, this slowdown is temporary and growth is expected to normalize. Eurofins Scientific provides testing and laboratory services to various industries, including pharmaceuticals, food, and environment. The company's organic growth has been impacted by factors such as reduced demand from certain clients and delays in project timelines. However, the company remains confident that its growth will recover as demand from key sectors such as biopharma and food testing is expected to increase. Eurofins Scientific has a strong presence in over 50 countries, with a network of over 900 laboratories. The company's revenue has been steadily increasing, with a reported revenue of 5.4 billion euros in 2022. Despite the current weakness, Eurofins Scientific is well-positioned to capitalize on growing demand for analytical testing and laboratory services.